propranolol has been researched along with nisoldipine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.81) | 18.7374 |
1990's | 9 (33.33) | 18.2507 |
2000's | 4 (14.81) | 29.6817 |
2010's | 10 (37.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herbette, LG; Mason, RP; Rhodes, DG | 1 |
Topliss, JG; Yoshida, F | 1 |
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brouillette, WJ; Brown, GB; Zha, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abete, P; Acanfora, D; Cicatiello, AM; Covelluzzi, F; De Caprio, L; Gallucci, F; Papa, M; Rengo, F | 1 |
Elliott, HL; McNally, C; Meredith, PA; Reid, JL | 1 |
Arrichiello, P; Bonaduce, D; Breglio, R; Lanzillo, T; Mazza, F; Morgano, G; Petretta, M | 1 |
Luo, SF; Yu, CL; Zhang, PW | 1 |
Leenen, FH; Levine, MA; Ogilvie, RI | 1 |
Duncker, DJ; Saxena, PR; Verdouw, PD | 2 |
Brooks, HL; Gross, GJ; Warltier, DC; Zyvoloski, MG | 1 |
Leenen, FH; Ogilvie, RI; Shaw-Stiffel, TA; Walker, SE | 1 |
Onodera, S; Sugawara, H; Tobise, K | 1 |
Battler, A; Blau, A; Eliahou, HE; Herz, I; Herzog, D; Schechter, P | 1 |
Kodama, Y; Matsunami, T; Miyahara, T; Saito, H; Sobue, T; Yokota, M | 1 |
2 review(s) available for propranolol and nisoldipine
Article | Year |
---|---|
Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
Topics: Cell Membrane; Chemical Phenomena; Chemistry, Physical; Kinetics; Lipid Bilayers; Membrane Lipids; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Structure-Activity Relationship | 1991 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for propranolol and nisoldipine
Article | Year |
---|---|
Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Nisoldipine; Propranolol; Randomized Controlled Trials as Topic | 1990 |
The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
Topics: Adult; Atenolol; Blood Pressure; Drug Interactions; Exercise; Heart Rate; Humans; Kidney; Liver; Male; Nisoldipine; Propranolol; Reference Values; Regional Blood Flow | 1991 |
[Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol].
Topics: Adult; Angina Pectoris; Coronary Circulation; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Myocardium; Nisoldipine; Oxygen Consumption; Propranolol | 1990 |
Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
Topics: Adult; Biological Availability; Calcium Channel Blockers; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Male; Nifedipine; Nisoldipine; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1988 |
Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol.
Topics: Adult; Biological Availability; Drug Administration Schedule; Drug Interactions; Hemodynamics; Humans; Male; Nisoldipine; Propranolol; Reference Values | 1994 |
20 other study(ies) available for propranolol and nisoldipine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
[Influences of 3,4,5-trihydroxystibene-3-beta-mono-D-glucoside on beat rate and injury of cultured newborn rat myocardial cells].
Topics: Animals; Cells, Cultured; Drugs, Chinese Herbal; Glucosides; L-Lactate Dehydrogenase; Myocardium; Nisoldipine; Phentolamine; Platelet Aggregation Inhibitors; Propranolol; Rats; Stilbenes | 1990 |
Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Hemodynamics; Nifedipine; Nimodipine; Nisoldipine; Propranolol; Swine; Vasodilation | 1988 |
The effects of nisoldipine alone and in combination with beta-adrenoceptor blockade on systemic haemodynamics and myocardial performance in conscious pigs.
Topics: Animals; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Hemodynamics; Myocardial Contraction; Nifedipine; Nisoldipine; Propranolol; Regional Blood Flow; Swine; Vascular Resistance | 1987 |
Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dogs; Female; Heart Rate; Hemodynamics; Hydralazine; Male; Nifedipine; Nisoldipine; Nitrendipine; Propranolol; Vasodilator Agents | 1984 |
Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol.
Topics: Animals; Antioxidants; Diltiazem; Fumarates; Heart; In Vitro Techniques; Lipid Peroxidation; Male; Myocardium; Nifedipine; Nisoldipine; Oxidation-Reduction; Oxygen; Propranolol; Rats; Rats, Sprague-Dawley | 1994 |
Cardiovascular effects of nisoldipine in essential hypertension.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nisoldipine; Propranolol; Radionuclide Ventriculography; Stroke Volume; Vascular Resistance | 1994 |
Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Angiography; Drug Evaluation; Electrocardiography; Exercise Test; Female; Heart; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Nisoldipine; Oxygen Consumption; Propranolol; Regression Analysis | 1993 |